07 Jan 2001

Blastoestimulina 2% - España

Updated: 07 Jan 2001

Blastoestimulina 2% polvo 5 g

Cicatrización de: heridas, quemaduras, úlceras tórpidas, úlceras de córnea, lesiones ulcerosas de la lepra etc.

Blastoestimulina 2% Description, Presentation and Dosage

Blastoestimulina 2% Description

Blastoestimulina 2% Drug Class Description


Blastoestimulina 2% Drug Description


Blastoestimulina 2% Presentation

Blastoestimulina 2% Presentation

Ampollas: dosis de ataque: 25 mg. (2,5 ml) vía i.m. o s.c. profunda al día ó 3 veces por semana; dosis de mantenimiento: 25 mg (2,5 ml) por vía i.m. cada 3 ó 4 días. Polvo: 1 a 3 aplicaciones al día. Aerosol: Pulverizar una ligera capa de producto sobre la herida, 1-3 veces al día.

Blastoestimulina 2% Manufacturer


Related Learning Zones

CSU Knowledge Centre

CSU Knowledge Centre

This Knowledge Centre is intended for allergists, immunologists, dermatologists and other healthcare professionals involved in the treatment and management of Chronic Spontaneous Urticaria (CSU). In this resource, you will find a disease overview, symposia highlights platform, video channel and additional resources including an events calendar and useful external links.

Type 2 Diabetes

Type 2 Diabetes

The Type 2 Diabetes Learning Zone comprises the Type 2 Diabetes Mellitus Knowledge Centre containing current prevalence statistics, treatment options, current diagnosis criteria from WHO and ADA, and latest guidelines; a Therapy Focus area compiling material on emerging insulin/incretin treatment combinations; and a free CME activity titled the ‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’. The CME is EACCME-accredited and worth 1 European CME credit (ECMEC). 

Blastoestimulina 2% Dosage

Blastoestimulina 2% Precautions, Reactions and Contraindications

Blastoestimulina 2% Special Precautions

Blastoestimulina 2% Adverse Reactions

Blastoestimulina 2% Adverse Reactions

Descamación de la piel.

Related Drugs - Dermatología

Back to top